Spots Global Cancer Trial Database for Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
Official Title: Biomarkers to Predict Cancer Therapy-Related Cardiotoxicity
Study ID: NCT06353191
Interventions
Study Description
Brief Summary: This study evaluates why some cancer patients but not others experience changes in heart function following treatment with chemotherapy.
Detailed Description: PRIMARY OBJECTIVE: I. To collect biospecimens from 1) patients who developed chemotherapy related cardiac toxicity (CRCT) and 2) patients who are at a high risk for developing CRCT identified prior to the onset of therapy. OUTLINE: This is an observational study. Patients undergo blood sample collection and have their medical records reviewed on study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact Details
Name: Nadine Norton, Ph.D.
Affiliation: Mayo Clinic
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
